Thomas Oxley (neurologist)

Last updated

Thomas Oxley
Thomas Oxley with Stentrode.tif
Dr. Thomas Oxley
Born
Education Monash University, MD
University of Melbourne,
PhD Neural Engineering
Years active2012-Present
Known forInterventional Neurologist
CEO, Synchron, Inc.
Medical career
ProfessionNeurointerventionalist, CEO
FieldNeurology
InstitutionsSynchron, Inc., University of Melbourne
Websitesynchron.com

Thomas J. Oxley is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. [1] Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. [2] Oxley is best known for founding Synchron, a company building next-generation brain computer interface solutions that has recently announced the first clinical data on a novel stent electrode (Stentrode) neural interface that is inserted through blood vessels. The company was initiated sometime after his cold-call to DARPA for funding, and has received substantial funding from the U.S. Defense Advanced Research Projects Agency (DARPA) and the Australian government to research this minimally-invasive neural interface technology. [3]

Contents

Work in brain-computer interface

While Oxley has been conducting research in motor systems since 2003, he is said to have conceived the idea for the Stentrode™ in 2007 and he led the original team at the University of Melbourne that created the technology. Stentrode is the first motor neuroprosthesis, a form of brain-computer interface implanted via the patient's blood vessels. Oxley's team in Australia was the only non-US-based group funded by DARPA as part of the Reliable Neural-Interface Technology (RE-NET) program and led by Professor Jack Judy.

Dr. Oxley announced in a 2018 TEDxSydney Talk [4] that the company, Synchron, would initiate clinical trials of the Stentrode device with the goal of assisting paralyzed patients to regain independence.

Just two years later, Oxley and Synchron published a first-in-human study on the device in the Journal of NeuroInterventional Surgery. The study showed the ability of two Australians with ALS to email, text, shop, and bank online using the Stentrode Device, and was conducted at Royal Melbourne Hospital. Earlier in 2020, the company had announced that it received Breakthrough Device status from the US Food and Drug Administration (FDA) for the Stentrode. [5]

Oxley's work has been published in major journals including Nature Biotechnology [6] and New England Journal of Medicine, [7] and he is the founder of three start-up companies: SmartStent (which was acquired by Synchron, Inc. [8] ), VascuLab and Synchron.

COVID-19 research

Oxley and his colleagues at Mount Sinai reported an increased incidence of stroke identified in patients under 50 years of age with COVID-19, which was published in New England Journal of Medicine in April 2020. [9]

Education

After earning bachelor's degrees in medical science, medicine and surgery from the University of Monash in Melbourne Australia, Oxley earned doctorate degrees in philosophy and neuroscience from the University of Melbourne. His training included advanced MRI imaging analysis, hardware device (stent) development, and electrophysiological signal processing. Oxley completed residencies in both internal medicine and neurology, as well as a stroke fellowship. From 2015 – 2017, Oxley completed an endovascular neurosurgery fellowship at Mount Sinai Hospital in New York under Professor J. Mocco and Professor Alejandro Berenstein.

Scientific career

Dr Oxley has published 100 internationally peer reviewed articles that have accumulated over 6500 citations, with 13 as first or last author and with an H Index of 20. [10]

Honors and awards

In 2018, Oxley won the 2018 Global Australian Advance Award Winner, [11] an award given to celebrate international Australians who exhibit remarkable talent, exceptional vision and ambition, the UNESCO Netexplo award for Innovation, [12] and was a finalist for the Congress of Neurological Surgeons Innovator of the Year Award. [13]

Related Research Articles

<span class="mw-page-title-main">Catheter</span> Medical tubes inserted in the body to extract or administer substances

In medicine, a catheter (/ˈkæθətər/) is a thin tube made from medical grade materials serving a broad range of functions. Catheters are medical devices that can be inserted in the body to treat diseases or perform a surgical procedure. Catheters are manufactured for specific applications, such as cardiovascular, urological, gastrointestinal, neurovascular and ophthalmic procedures. The process of inserting a catheter is called catheterization.

<span class="mw-page-title-main">Interventional radiology</span> Medical subspecialty

Interventional radiology (IR) is a medical specialty that performs various minimally-invasive procedures using medical imaging guidance, such as x-ray fluoroscopy, computed tomography, magnetic resonance imaging, or ultrasound. IR performs both diagnostic and therapeutic procedures through very small incisions or body orifices. Diagnostic IR procedures are those intended to help make a diagnosis or guide further medical treatment, and include image-guided biopsy of a tumor or injection of an imaging contrast agent into a hollow structure, such as a blood vessel or a duct. By contrast, therapeutic IR procedures provide direct treatment—they include catheter-based medicine delivery, medical device placement, and angioplasty of narrowed structures.

<span class="mw-page-title-main">Brain–computer interface</span> Direct communication pathway between an enhanced or wired brain and an external device

A brain–computer interface (BCI), sometimes called a brain–machine interface (BMI) or smartbrain, is a direct communication pathway between the brain's electrical activity and an external device, most commonly a computer or robotic limb. BCIs are often directed at researching, mapping, assisting, augmenting, or repairing human cognitive or sensory-motor functions. They are often conceptualized as a human–machine interface that skips the intermediary component of the physical movement of body parts, although they also raise the possibility of the erasure of the discreteness of brain and machine. Implementations of BCIs range from non-invasive and partially invasive to invasive, based on how close electrodes get to brain tissue.

Neurotechnology encompasses any method or electronic device which interfaces with the nervous system to monitor or modulate neural activity.

Mechanical thrombectomy, or simply thrombectomy, is the removal of a blood clot (thrombus) from a blood vessel, often and especially endovascularly as an interventional radiology procedure called endovascular thrombectomy (EVT). It thus contrasts with thrombolysis by thrombolytic medications, as either alternative or complement thereto. It is commonly performed in the cerebral arteries as treatment to reverse the ischemia in some ischemic strokes. Open vascular surgery versions of thrombectomy also exist. The effectiveness of thrombectomy for strokes was confirmed in several randomised clinical trials conducted at various medical centers throughout the United States, as reported in a seminal multistudy report in 2015.

Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons. Some brain implants involve creating interfaces between neural systems and computer chips. This work is part of a wider research field called brain–computer interfaces.

<span class="mw-page-title-main">Carotid artery dissection</span> Human disease

Carotid artery dissection is a separation of the layers of the artery wall in the carotid arteries supplying oxygen-bearing blood to the head. It is the most common cause of stroke in younger adults. The term 'cervical artery dissection' should also be considered in the context of this article.

Michael L. Marin is an American vascular surgeon. Together with Drs. Frank Veith, Juan C. Parodi and Claudio J. Schonholz, he was the first in the United States to perform minimally invasive aortic aneurysm surgery. In 2004, he was the first doctor to implant an intravascular telemetric monitor -- a device that alerts to physicians any leakage in aortic stent-grafts.

Joshua B. Bederson is an American neurosurgeon, Leonard I. Malis, MD/Corinne and Joseph Graber Professor of Neurosurgery, and System Chair of Neurosurgery at the Mount Sinai Health System in New York City. He is a Fellow of the American College of Surgeons, and an attending neurosurgeon at The Mount Sinai Hospital.

The BCI Research Award is an annual award for innovative research in the field of brain-computer interfaces. It is organized by the BCI Award Foundation. The prize is $3000 for first, $2000 for second, and $1000 for third place. The prizes are provided by g.tec medical engineering, Cortec, Intheon and IEEE Brain.. Christoph Guger and Dean Krusienski are the chairmen of the Foundation.

Interventional neuroradiology (INR) also known as neurointerventional surgery (NIS), endovascular therapy (EVT), endovascular neurosurgery, and interventional neurology is a medical subspecialty of neurosurgery, neuroradiology, intervention radiology and neurology specializing in minimally invasive image-based technologies and procedures used in diagnosis and treatment of diseases of the head, neck, and spine.

Brain technology, or self-learning know-how systems, defines a technology that employs latest findings in neuroscience. [see also neuro implants] The term was first introduced by the Artificial Intelligence Laboratory in Zurich, Switzerland, in the context of the Roboy project. Brain Technology can be employed in robots, know-how management systems and any other application with self-learning capabilities. In particular, Brain Technology applications allow the visualization of the underlying learning architecture often coined as “know-how maps”.

Camilo Ramiro Gomez, is an American neurologist, medical educator, and researcher. He is one of the first 100 vascular neurologists certified by the American Board of Psychiatry and Neurology (ABPN), and one of the founders of the subspecialty of interventional neurology in the United States.

<span class="mw-page-title-main">Bionics Institute</span>

The Bionics Institute is an Australian medical research institute focusing on medical device development. It is located in Melbourne, Australia.

<span class="mw-page-title-main">Stent-electrode recording array</span> Stent-mounted electrode array that is permanently implanted into a blood vessel in the brain

Stentrode is a small stent-mounted electrode array permanently implanted into a blood vessel in the brain, without the need for open brain surgery. It is in clinical trials as a brain–computer interface (BCI) for people with paralyzed or missing limbs, who will use their neural signals or thoughts to control external devices, which currently include computer operating systems. The device may ultimately be used to control powered exoskeletons, robotic prosthesis, computers or other devices.

Alexander Coon is an American neurosurgeon who is the Director of Endovascular and Cerebrovascular Neurosurgery at the Carondelet Neurological Institute of St. Joseph's and St. Mary's Hospitals in Tucson, Arizona. He was previously the Director of Endovascular Neurosurgery at the Johns Hopkins Hospital and an assistant professor of neurosurgery, Neurology, and Radiology at the Johns Hopkins Hospital. He is known for his work in cerebrovascular and endovascular neurosurgery and his research in neuroendovascular devices and clinical outcomes in the treatment of cerebral aneurysms, subarachnoid hemorrhage, and AVMs.

Elad I. Levy is an American neurosurgeon, researcher, and innovator who played a major role in the development and testing of thrombectomy, which improved quality of life and survival of stroke patients. He has focused his career and research on developing evidence based medicine and literature showing the benefits of thrombectomy for the treatment of stroke. He is currently Professor of Neurosurgery and Radiology, and the L. Nelson Hopkins, MD Professor Endowed Chair of the Department of Neurosurgery at the State University of New York at Buffalo (SUNY).

<span class="mw-page-title-main">John-Ross Rizzo</span>

John-Ross (JR) Rizzo, M.D., M.S.C.I., is an American physician-scientist known for his significant contributions to the field of healthcare and rehabilitation. He holds the prestigious Melamid Professorship in Rehabilitation (Disability) Medicine at NYU Langone Medical Center. Dr. Rizzo has made remarkable strides in the areas of disability inclusion, innovation, and equity within the medical community. At NYU Langone Medical Center, Dr. Rizzo serves as the first Health System Director of Disability Inclusion, a role that reflects his commitment to promoting accessibility and inclusivity within healthcare. Additionally, he holds the position of Vice Chair of Innovation and Equity for the Department of Physical Medicine and Rehabilitation at the Rusk Institute of Rehabilitation Medicine. Dr. Rizzo's impact extends beyond traditional medical boundaries, as he holds cross-appointments in multiple departments. His affiliations include the Department of Neurology, where he contributes to the advancement of neurological sciences, as well as the Departments of Biomedical & Mechanical and Aerospace Engineering at New York University Tandon School of Engineering. Within Tandon, he also contributes to the Electrical and Computer Engineering Department and plays a vital role as the associate director of Healthcare for the NYU Wireless Center. Dr. Rizzo has published 125 peer-reviewed publications, contributed to 12 textbooks, and co-authored many conference proceedings. He has been funded by 5 federal agencies and lead/co-lead grants that, in total, well exceed $10M.

<span class="mw-page-title-main">Chet Moritz</span> American neural engineer

Chet T. Moritz is an American neural engineer, neuroscientist, physiologist, and academic researcher. He is a Professor of Electrical and Computer Engineering, and holds joint appointments in the School of Medicine departments of Rehabilitation Medicine, and Physiology & Biophysics at the University of Washington.

Precision Neuroscience is an American brain–computer interface (BCI) company based in New York City and with offices in Mountain View, California, Addison, Texas and Minneapolis, Minnesota.

References

  1. "Thomas Oxley at Mt. Sinai". www.mountsinai.org. Retrieved 27 June 2019.
  2. "University of Melbourne Vascular Bionics Laboratory". medicine.unimelb.edu.au. 2 April 2019. Retrieved 27 June 2019.
  3. "Thomas Oxley, University of Melbourne". findanexpert.unimelb.edu.au. Retrieved 27 June 2019.
  4. "A Digital Spinal Cord that Streams Your Thoughts". YouTube. Retrieved 27 June 2019.
  5. Hollis, Liz. "FDA Grants Breakthrough Designation to Synchron's Stentrode Brain Computer Interface". BioWorld. Retrieved 23 November 2020.
  6. Oxley, Thomas (2016). "Minimally Invasive Endovascular Stent-Electrode Array for High-Fidelity, Chronic Recordings of Cortical Neural Activity". Nature Biotechnology. 34 (3): 320–7. doi:10.1038/nbt.3428. PMID   26854476. S2CID   205282364 . Retrieved 27 June 2019.
  7. Campbell, Bruce C.V.; Mitchell, Peter J.; Kleinig, Timothy J.; Dewey, Helen M.; Churilov, Leonid; Yassi, Nawaf; Yan, Bernard; Dowling, Richard J.; Parsons, Mark W.; Oxley, Thomas J.; Wu, Teddy Y.; Brooks, Mark; Simpson, Marion A.; Miteff, Ferdinand; Levi, Christopher R.; Krause, Martin; Harrington, Timothy J.; Faulder, Kenneth C.; Steinfort, Brendan S.; Priglinger, Miriam; Ang, Timothy; Scroop, Rebecca; Barber, P. Alan; McGuinness, Ben; Wijeratne, Tissa; Phan, Thanh G.; Chong, Winston; Chandra, Ronil V.; Bladin, Christopher F.; et al. (2015). "Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection". New England Journal of Medicine. 372 (11): 1009–1018. doi: 10.1056/NEJMoa1414792 . PMID   25671797. S2CID   4688893.
  8. "Endovascular Start-Up Synchron, Inc. Appoints Neurovascular Veteran Martin Dieck as Chairman". businesswire.com. Business Wire. 21 April 2016. Retrieved 27 June 2019.
  9. Oxley, Thomas (2020). "Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young". The New England Journal of Medicine. 382 (20): e60. doi:10.1056/NEJMc2009787. PMC   7207073 . PMID   32343504.
  10. "Thomas J Oxley". Google Scholar. Retrieved 2 December 2020.
  11. 1 2 "Dr. Thomas Oxley Announced as Overall Winner in 2018 Advance Awards". advance.org. Archived from the original on 27 June 2019. Retrieved 27 June 2019.
  12. 1 2 "Stentrode". netexplo.org. Netexplo Observatory. Retrieved 27 June 2019.
  13. "Awards". cns.org. Congress of Neurological Surgeons. Retrieved 27 June 2019.
  14. "VIC Nominee Australian of the Year 2021". Australian of the Year Awards. Australia Day. Archived from the original on 27 November 2020. Retrieved 1 December 2020.
  15. "Dr. Thomas Oxley". advance.org. Retrieved 27 June 2019.
  16. "Honouring Victoria's Brightest Medical Researchers". premier.vic.gov.au. Delivering. Retrieved 27 June 2019.
  17. "The Winners of the Annual BCI Award 2016". blog.gtec.at. G Tec. Retrieved 27 June 2019.